Prot# AP23573-04-201: A Phase II Study of AP23573, an mTOR Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/17/05 → 10/2/09

Funding

  • ARIAD Pharmaceuticals, Inc. (AP23573-04-201)